Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Medtech 360 | Market Insights | US | 2024

The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2032.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Biosurgical Agents – Market Insights – Latin America (Supplemental)
The biosurgical agent market in Latin America will observe modest growth through 2033, primarily driven by the increasing number of procedures utilizing biosurgical agents, combined with favorable…
Report
Biosurgical Agents – Market Insights – Europe (Supplemental)
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by the growing number of procedures in which in biosurgical agents are used,…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth over the forecast period, driven by the rising volume of surgical procedures and heightened awareness of the…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…